Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies?
about
New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid BiopsiesThe circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluidsSimultaneous detection of nucleic acid and protein using gold nanoparticles and lateral flow deviceMethyl-binding domain protein-based DNA isolation from human blood serum combines DNA analyses and serum-autoantibody testing.Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation.Circulating DNA in rheumatoid arthritis: pathological changes and association with clinically used serological markers.Circulating DNA level is negatively associated with the long-term survival of hepatocellular carcinoma patients.A novel use of biomarkers in the modeling of cancer activity based on the theory of endobiogeny.A new perspective on Darwin's Pangenesis.Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients.Comparative study of seven commercial kits for human DNA extraction from urine samples suitable for DNA biomarker-based public health studies.Preoperative plasma transcript AA454543 level is an independent prognostic factor for hepatocellular carcinoma after partial hepatectomyDiagnostic and prognostic value of metastasis inducer S100A4 transcripts in plasma of colon, rectal, and gastric cancer patients.Advances in the medical research and clinical applications on the plasma DNACell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylationAn international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma.MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis.A new blood collection device minimizes cellular DNA release during sample storage and shipping when compared to a standard device.Salivary protein factors are elevated in breast cancer patients.DNA methylation as a biomarker in breast cancer.Circulating miRNA and cancer diagnosis.Cell-free and cell-bound circulating nucleic acid complexes: mechanisms of generation, concentration and content.MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential.Qualitative and quantitative characteristics of the extracellular DNA delivered to the nucleus of a living cell.Noncoding RNAs in Cancer Diagnosis.Utilization of paramagnetic microparticles for automated isolation of free circulating mRNA as a new tool in prostate cancer diagnostics.249ser p53 mutation in the serum of black southern African patients with hepatocellular carcinoma.Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer.Chimeric External Control to Quantify Cell Free DNA in Plasma Samples by Real Time PCR.Trans-oral brush biopsies and quantitative PCR for EBV DNA detection and screening of nasopharyngeal carcinoma.Circulating cell-free and Epstein-Barr virus DNA in pediatric B-non-Hodgkin lymphomas.Release of DNA from dead and dying lymphocyte and monocyte cell lines in vitro.Hepatocellular carcinoma and liver cirrhosis TP53 mutation analysis reflects a moderate dietary exposure to aflatoxins in Espírito Santo State, Brazil.On-chip wavelength multiplexed detection of cancer DNA biomarkers in blood.RNA profiling of cell-free saliva using microarray technology.Assessment of diabetic retinopathy by measuring retina-specific mRNA in blood.Advances in liquid biopsy on-chip for cancer management: Technologies, biomarkers, and clinical analysis.Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective study.Isolation and comparative study of cell-free nucleic acids from human urine.Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays.
P2860
Q26748881-F9502526-A1E8-478A-A931-C851A117B5F9Q26825022-42D534F8-AD82-4012-9EC2-A129700E646BQ30434294-06D920D1-40FB-4565-907D-F332D2683B51Q31030113-3CD0A67D-1CC8-4EC6-886E-29537A19F6E7Q31037974-5D4DDD27-B464-45E4-9D42-42276ED06F09Q33629819-E4CAF8B3-99C4-4EB8-8A37-D89BE9E36061Q33868324-DD38D1D8-BB0A-4B48-B24C-B2517AA7DD85Q33924546-636A4DA9-4FC7-4D54-8FD9-9F1CAEB1F007Q34011253-D4CBDF5E-6CDE-4961-B5F2-B2E8D43B65E2Q34267943-3A413C39-B81C-4EE8-AB7E-1ADFA68F2B26Q34305390-7F3D8B52-4DD9-4662-83AE-B3A831A0DF20Q35060308-962066ED-D155-43E9-9F43-C23A58C090E2Q35083652-1E581153-5BCB-4165-B725-FA52BB35418DQ36508665-43896909-AD70-4B77-B6DF-CFF2C475BF98Q36614162-2F7D738A-9299-4542-9DE6-8DD50073229CQ36778016-E0F9E743-6D64-4416-AA26-0B3A1B0F77D4Q36986986-FFC29403-15FE-41A3-828C-C5549FCB7B65Q37108873-7BFE6B82-9DF7-4511-8F1F-99D97D880615Q37390490-F1E53659-E7A3-4BB1-94E8-802598EA189EQ37620392-B406A9E9-41E4-44A4-BF16-D89A7D2167E5Q37657193-FE7A561E-8D62-4C25-BD3A-80F4B9B474E0Q38002456-EF141B49-1899-41D2-9BF1-9DE078CB2891Q38599607-EE61301A-0907-4B03-AA35-AD7B3D7AC15EQ38779025-93B00F1C-B8AE-4376-9858-52BA37117ABBQ38885507-21ACA4E6-F4BC-4B98-9E92-CFE9F1A18341Q39125423-1EAEDC05-254B-48A1-A455-B3783573F10CQ39724980-0202CE3F-A836-4049-BA56-55E75B6B0BE3Q39766437-AE7A9667-89E0-4CDA-B1AA-44F56637804CQ39798654-FA2CFED5-EC2C-4A11-850A-C95C89A0D219Q42239637-B2F9875F-1C81-44BC-BFAB-ECB69C4B3EF1Q43063274-7B323E10-3E93-4928-B183-0E788828E544Q44967041-5AA32EAD-3E26-4257-9F46-98C13D498B70Q45180099-91FA5791-AB06-4FF1-ACA7-10F77E1E0EABQ45976127-5A141C21-623E-4A98-81CE-38C00F3A1212Q46759712-3AB44960-3C35-45B1-9C3A-A0AFA7434FDCQ49177421-A64C6BC1-6128-4F5B-B40A-480081170A23Q49502117-64EF5193-0184-47BE-BA83-724C78A2DFD4Q51122492-CA1565A7-1F15-46E4-9124-D0C4735C7A55Q51776655-D9D3033D-92EA-48C7-A0C4-3778B51E34DEQ54625845-DF8F7501-8CF3-4578-800D-E0B43334EF5D
P2860
Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies?
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Circulating nucleic acids in p ...... large-scale clinical studies?
@ast
Circulating nucleic acids in p ...... large-scale clinical studies?
@en
type
label
Circulating nucleic acids in p ...... large-scale clinical studies?
@ast
Circulating nucleic acids in p ...... large-scale clinical studies?
@en
prefLabel
Circulating nucleic acids in p ...... large-scale clinical studies?
@ast
Circulating nucleic acids in p ...... large-scale clinical studies?
@en
P2093
P356
P1476
Circulating nucleic acids in p ...... large-scale clinical studies?
@en
P2093
Hugh Mulcahy
Maurice Stroun
Philippe Anker
P304
P356
10.1002/IJC.10791
P577
2003-01-01T00:00:00Z